Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's medicines using this technology, and more.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

'Thank Goodness for Taylor Swift': CEO on Hyatt's State of Affairs

Join Barron’s Andy Serwer as he sits down with top CEOs and business leaders to discuss the biggest stories in business, including the economy, emerging technologies such as artificial intelligence, leadership, corporate culture, and more. Every week, our guests offer unique insight into their companies and the broader corporate world to help you see around corners and understand what's next. At Barron’s also unpacks the human side of top executives, including the challenges and experiences that made them into the leaders they are today.